Search Results - "ABBOUD, Camille N"

Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide by Goldsmith, Scott R, Slade, Michael, DiPersio, John F, Westervelt, Peter, Lawrence, Steven J, Uy, Geoffrey L, Abboud, Camille N, Vij, Ravi, Schroeder, Mark A, Fehniger, Todd A, Dubberke, Erik R, Trinkaus, Kathryn, Romee, Rizwan

Get full text

Selinexor combined with cladribine, cytarabine, and filgrastim in relapsed or refractory acute myeloid leukemia by Abboud, Ramzi, Chendamarai, Ezhilarasi, Rettig, Michael P, Trinkaus, Kathryn M, Riedell, Peter A, Abboud, Camille N, Ghobadi, Armin, Pusic, Iskra, Stockerl-Goldstein, Keith, Schroeder, Mark A, Vij, Ravi, Westervelt, Peter, DiPersio, John F, Uy, Geoffrey L

Get full text

Control of Plasma Uric Acid in Adults at Risk for Tumor Lysis Syndrome: Efficacy and Safety of Rasburicase Alone and Rasburicase Followed by Allopurinol Compared With Allopurinol Alone—Results of a Multicenter Phase III Study by Jorge Cortes, Joseph O. Moore, Richard T. Maziarz, Meir Wetzler, Michael Craig, Jeffrey Matous, Selina Luger, Bimalangshu R. Dey, Gary J. Schiller, Dat Pham, Camille N. Abboud, Muthuswamy Krishnamurthy, Archie Brown, Jr, Abderrahmane Laadem, Karen Seiter

“…Rasburicase is effective in controlling plasma uric acid in pediatric patients with hematologic malignancies. This study in adults evaluated safety of and…”
Get full text

Decitabine salvage for TP53 -mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy by Ferraro, Francesca, Gruszczynska, Agata, Ruzinova, Marianna B, Miller, Christopher A, Percival, Mary Elizabeth, Uy, Geoffrey L, Pusic, Iskra, Jacoby, Meagan A, Christopher, Mathew J, Kim, Miriam Y, Westervelt, Peter, Cashen, Amanda F, Schroeder, Mark A, DiPersio, John F, Abboud, Camille N, Wartman, Lukas D, Gao, Feng, Link, Daniel C, Ley, Timothy J, Welch, John S

Get full text

Leukostasis in adult acute hyperleukocytic leukemia: a clinician's digest by Ali, Alaa M., Mirrakhimov, Aibek E., Abboud, Camille N., Cashen, Amanda F.

“…Leukostasis is a poorly understood and life‐threatening complication of acute hyperleukocytic leukemia. The incidence of hyperleukocytosis and leukostasis…”
Get full text

Serendipity: decitabine monotherapy induced complete molecular response in a 77-year-old patient with acute promyelocytic leukemia by Abboud, Ramzi, Han, Se Young, Duncavage, Eric J, Cashen, Amanda F, Shirai, Cara Lunn, Welch, John S, DiPersio, John F, Abboud, Camille N

Get full text

Phase I study of cladribine, cytarabine, granulocyte colony stimulating factor (CLAG regimen) and midostaurin and all-trans retinoic acid in relapsed/refractory AML by Ramsingh, Giridharan, Westervelt, Peter, McBride, Ali, Stockerl-Goldstein, Keith, Vij, Ravi, Fiala, Mark, Uy, Geoffrey, Cashen, Amanda, DiPersio, John F., Abboud, Camille N.

“…We conducted a phase I study using midostaurin (25 or 50 mg orally twice daily), all- trans retinoic acid (ATRA) and CLAG chemotherapy to target multiple…”
Get full text

A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia by Uy, Geoffrey L., Rettig, Michael P., Motabi, Ibraheem H., McFarland, Kyle, Trinkaus, Kathryn M., Hladnik, Lindsay M., Kulkarni, Shashikant, Abboud, Camille N., Cashen, Amanda F., Stockerl-Goldstein, Keith E., Vij, Ravi, Westervelt, Peter, DiPersio, John F.

“…The interaction of acute myeloid leukemia (AML) blasts with the leukemic microenvironment is postulated to be an important mediator of resistance to…”
Get full text

Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy by Berrien-Elliott, Melissa M., Becker-Hapak, Michelle, Cashen, Amanda F., Jacobs, Miriam, Wong, Pamela, Foster, Mark, McClain, Ethan, Desai, Sweta, Pence, Patrick, Cooley, Sarah, Brunstein, Claudio, Gao, Feng, Abboud, Camille N., Uy, Geoffrey L., Westervelt, Peter, Jacoby, Meagan A., Pusic, Iskra, Stockerl-Goldstein, Keith E., Schroeder, Mark A., DiPersio, John F., Soon-Shiong, Patrick, Miller, Jeffrey S., Fehniger, Todd A.

“…Natural killer (NK) cells are a promising alternative to T cells for cancer immunotherapy. Adoptive therapies with allogeneic, cytokine-activated NK cells are…”
Get full text

Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia by Berrien-Elliott, Melissa M, Foltz, Jennifer A, Russler-Germain, David A, Neal, Carly C, Tran, Jennifer, Gang, Margery, Wong, Pamela, Fisk, Bryan, Cubitt, Celia C, Marin, Nancy D, Zhou, Alice Y, Jacobs, Miriam T, Foster, Mark, Schappe, Timothy, McClain, Ethan, Kersting-Schadek, Samantha, Desai, Sweta, Pence, Patrick, Becker-Hapak, Michelle, Eisele, Jeremy, Mosior, Matthew, Marsala, Lynne, Griffith, Obi L, Griffith, Malachi, Khan, Saad M, Spencer, David H, DiPersio, John F, Romee, Rizwan, Uy, Geoffrey L, Abboud, Camille N, Ghobadi, Armin, Westervelt, Peter, Stockerl-Goldstein, Keith, Schroeder, Mark A, Wan, Fei, Lie, Wen-Rong, Soon-Shiong, Patrick, Petti, Allegra A, Cashen, Amanda F, Fehniger, Todd A

“…Natural killer (NK) cells are innate lymphoid cells that eliminate cancer cells, produce cytokines, and are being investigated as a nascent cellular…”
Get more information

Impact of Mobilization and Remobilization Strategies on Achieving Sufficient Stem Cell Yields for Autologous Transplantation by Pusic, Iskra, Jiang, Shi Yuan, Landua, Scott, Uy, Geoffrey L, Rettig, Michael P, Cashen, Amanda F, Westervelt, Peter, Vij, Ravi, Abboud, Camille N, Stockerl-Goldstein, Keith E, Sempek, Diane S, Smith, Angela L, DiPersio, John F

“…Abstract The purpose of this article was to examine historic institutional autologous stem cell mobilization practices and evaluate factors influencing…”
Get full text

Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft by Schroeder, Mark A., Rettig, Michael P., Lopez, Sandra, Christ, Stephanie, Fiala, Mark, Eades, William, Mir, Fazia A., Shao, Jin, McFarland, Kyle, Trinkaus, Kathryn, Shannon, William, Deych, Elena, Yu, Jinsheng, Vij, Ravi, Stockerl-Goldstein, Keith, Cashen, Amanda F., Uy, Geoffrey L., Abboud, Camille N., Westervelt, Peter, DiPersio, John F.

“…A single subcutaneous (SC) injection of plerixafor results in rapid mobilization of hematopoietic progenitors, but fails to mobilize 33% of normal allogeneic…”
Get full text

Protective Effect of Cytomegalovirus Reactivation on Relapse after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients Is Influenced by Conditioning Regimen by Manjappa, Shivaprasad, Bhamidipati, Pavan Kumar, Stokerl-Goldstein, Keith E, DiPersio, John F, Uy, Geoffrey L, Westervelt, Peter, Liu, Jingxia, Schroeder, Mark A, Vij, Ravi, Abboud, Camille N, Fehniger, Todd A, Cashen, Amanda F, Pusic, Iskra, Jacoby, Meagan, Meera, Srinidhi J, Romee, Rizwan

“…Abstract Cytomegalovirus (CMV) reactivation after allogeneic hematopoietic cell transplant (allo-HCT) has been associated with a reduced risk of relapse in…”
Get full text

Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment response by Jacoby, Meagan A, Duncavage, Eric D, Khanna, Ajay, Chang, Gue Su, Nonavinkere Srivatsan, Sridhar, Miller, Christopher A, Gao, Feng, Robinson, Josh, Shao, Jin, Fulton, Robert S, Fronick, Catrina C, O'Laughlin, Michelle, Heath, Sharon E, Brendel, Kimberly, Chavez, Monique, DiPersio, John F, Abboud, Camille N, Stockerl-Goldstein, Keith, Westervelt, Peter, Cashen, Amanda, Pusic, Iskra, Oh, Stephen T, Welch, John S, Wells, Denise A, Loken, Michael R, Uy, Geoffrey L, Walter, Matthew J

“…Accurate assessment of therapy response in myelodysplastic neoplasm (MDS) has been challenging. Directly monitoring mutational disease burden may be useful,…”
Get full text

Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F by Stein, Brady L, Oh, Stephen T, Berenzon, Dmitriy, Hobbs, Gabriela S, Kremyanskaya, Marina, Rampal, Raajit K, Abboud, Camille N, Adler, Kenneth, Heaney, Mark L, Jabbour, Elias J, Komrokji, Rami S, Moliterno, Alison R, Ritchie, Ellen K, Rice, Lawrence, Mascarenhas, John, Hoffman, Ronald

“…Polycythemia vera (PV) is a chronic myeloproliferative neoplasm that is associated with a substantial symptom burden, thrombohemorrhagic complications, and…”
Get full text

Rapid Method for Detection of Mutations in the Nucleophosmin Gene in Acute Myeloid Leukemia by Laughlin, Todd S, Becker, Michael W, Liesveld, Jane L, Mulford, Deborah A, Abboud, Camille N, Brown, Patrick, Rothberg, Paul G

“…Mutations in exon 12 of the nucleophosmin gene ( NPM1 ) that cause the encoded protein to abnormally relocate to the cytoplasm are found at diagnosis in about…”
Get full text

Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia by Desai, Pinkal M, Brown, Janice, Gill, Saar, Solh, Melham M, Akard, Luke P, Hsu, Jack W, Ustun, Celalettin, Andreadis, Charalambos, Frankfurt, Olga, Foran, James M, Lister, John, Schiller, Gary J, Wieduwilt, Matthew J, Pagel, John M, Stiff, Patrick J, Liu, Delong, Khan, Irum, Stock, Wendy, Kambhampati, Suman, Tallman, Martin S, Morris, Lawrence, Edwards, John, Pusic, Iskra, Kantarjian, Hagop M, Mamelok, Richard, Wong, Alicia, Van Syoc, Rodney, Kellerman, Lois, Panuganti, Swapna, Mandalam, Ramkumar, Abboud, Camille N, Ravandi, Farhad

“…Standard cytotoxic induction chemotherapy for acute myeloid leukemia (AML) results in prolonged neutropenia and risk of infection. Romyelocel-L is a universal,…”
Get full text

Real-world safety experience of tevagrastim/ratiograstim/biograstim and tbo-filgrastim, short-acting recombinant human granulocyte colony-stimulating factors by Abboud, Camille N., Lang, Nicole, Fung, Henry, Lammerich, Andreas, Buchner, Anton, Liu, Patrick, Mueller, Udo, Pettengell, Ruth, Diel, Ingo J., Link, Hartmut, Pathak, Ashutosh

“…Purpose Recombinant granulocyte colony-stimulating factors (rG-CSFs), such as filgrastim, are administered to prevent complications in patients receiving…”
Get full text

A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia by Fehniger, Todd A., Uy, Geoffrey L., Trinkaus, Kathryn, Nelson, Alissa D., Demland, Jeffery, Abboud, Camille N., Cashen, Amanda F., Stockerl-Goldstein, Keith E., Westervelt, Peter, DiPersio, John F., Vij, Ravi

“…Older patients with acute myeloid leukemia (AML) have limited treatment options and a poor prognosis, thereby warranting novel therapeutic strategies. We…”
Get full text

ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study by Maris, Michael, Salles, Gilles, Kim, Won Seog, Kim, Tae Min, Lyons, Roger M., Arellano, Martha, Karmali, Reem, Schiller, Gary, Cull, Elizabeth, Abboud, Camille N., Batlevi, Connie, Kagiampakis, Ioannis, Rebelatto, Marlon C., Lee, Young, Kirby, Lyndon C., Wang, Fujun, Bothos, John, Townsley, Danielle M., Fathi, Amir T., Ribrag, Vincent

“…Background MEDI7247 is a first-in-class antibody-drug conjugate (ADC) consisting of an anti-sodium-dependent alanine-serine-cysteine transporter 2…”
Get full text